In addition, in a murine model of acute pseudomonas aeruginosa lung infection, BET inhibition diminished inflammatory conditions without exacerbating infection, suggesting that BET inhibitors may be a potential therapeutic candidate in patients with cystic fibrosis [100]. This evidence concerns the gene DNER and cystic fibrosis.